2Melol G,Steinhelper ME,Pang SC,et al.ANP in regulation of arterial pressure and fluid-electolyte balance:lessons from genetic mouse models[J].Physiol Genomic,2003,3(1):45-58.
3Losonczy G,Kriston T,Szabo A.Malegender predisposes to development of endotoxic shock in the rat[J].Cardiovasc Res,2000,47(1):183-191.
4Knowl ESJ W,Espositog,Maol,et al.Pressure independent enhancement of cardiac hypertrophy in natriuretic peptide receptor adeficient mice[J].J Clin Invest,2001,107(8):975-984.
5Brockhoffc,Warnhol TZA,Munzel T.Atrial natriuretic peptides:diagnostic and therapeutic potential[J].Ther Umsch,2000,57(5):305-312.
6Honing MH,Smits P,Morrson PJ,et al.C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarixation in human resistance vessels[J].Hyperension,2001,37:1179-1183.
7Marakazu K,Kenichi Y,Kensaku M,et al.Effects of cardiac natriuretic peptides on oxidized low-density lipoprotein and lysophosphatidylcholine-iduced hunman mesarngial cell nugration[J].Hypertension,2000,35:971-977.
8Nagaya N,Nishikimi T,Uematsu M,et al.Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension compling atrial sepial defeet[J].Am Heart J,1998,136,297-301.
9Losonczy G,Kriston T,Szabo A.Male gender predisposes to development of endotoxic shock in[J].Cardiovasc Res,2000,47(1):183-191.
10Stein BC,Levin RI.Natriuretic peptides:physiology,therapeutic potential and risk stratification in ischemic heart disease[J].Am Heart J,1998,35:914-923.
